Area of research
Genetics · Molecular Biology
Research interest
Research interests include Inflammatory Bowel Disease, Gut microbiota and health, Microscopic Colitis, and Clostridium difficile and Clostridium perfringens research.
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference
International consensus statement on microbiome testing in clinical practice
Gut microbiota strain richness is species specific and affects engraftment
Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission
Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profiling
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics
Microbial determinants of effective donors in faecal microbiota transplantation for UC
Vedolizumab has longer persistence than infliximab as a first-line biological agent but not as a second-line biological agent in moderate-to-severe ulcerative colitis: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial
Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study
Assisted Reproductive Technology in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis
Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study
Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis
Defined microbiota transplant restores Th17/RORγt <sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis